title: Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation.
authors.affiliation: a Hematology Unit, Department of Onco-Hematology , AO Of Cosenza , Cosenza , Italy ;
authors.forename: Ernesto
authors.initials: E
authors.lastname: Vigna
authors.affiliation: a Hematology Unit, Department of Onco-Hematology , AO Of Cosenza , Cosenza , Italy ;
authors.forename: Massimo
authors.initials: M
authors.lastname: Gentile
authors.affiliation: a Hematology Unit, Department of Onco-Hematology , AO Of Cosenza , Cosenza , Italy ;
authors.forename: Giovanna
authors.initials: G
authors.lastname: Giagnuolo
authors.affiliation: a Hematology Unit, Department of Onco-Hematology , AO Of Cosenza , Cosenza , Italy ;|b Biotechnology Research Unit, Aprigliano, AO/ASP Of Cosenza , Cosenza , Italy ;
authors.forename: Anna Grazia
authors.initials: AG
authors.lastname: Recchia
authors.affiliation: a Hematology Unit, Department of Onco-Hematology , AO Of Cosenza , Cosenza , Italy ;|b Biotechnology Research Unit, Aprigliano, AO/ASP Of Cosenza , Cosenza , Italy ;
authors.forename: Sabrina
authors.initials: S
authors.lastname: Bossio
authors.affiliation: a Hematology Unit, Department of Onco-Hematology , AO Of Cosenza , Cosenza , Italy ;|b Biotechnology Research Unit, Aprigliano, AO/ASP Of Cosenza , Cosenza , Italy ;
authors.forename: Laura
authors.initials: L
authors.lastname: De Stefano
authors.affiliation: c Nuclear Medicine Unit, Department of Onco-Hematology , AO Of Cosenza , Cosenza , Italy.
authors.forename: Rosellina
authors.initials: R
authors.lastname: Morelli
authors.affiliation: a Hematology Unit, Department of Onco-Hematology , AO Of Cosenza , Cosenza , Italy ;|b Biotechnology Research Unit, Aprigliano, AO/ASP Of Cosenza , Cosenza , Italy ;
authors.forename: Fortunato
authors.initials: F
authors.lastname: Morabito
mesh_terms: D000367:Age Factors; D000368:Aged; D000069439:Dasatinib; D005260:Female; D006801:Humans; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D012074:Remission Induction; D013997:Time Factors; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D000069439:Dasatinib